167 related articles for article (PubMed ID: 11447735)
1. Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells.
Wołczynski S; Surazyński A; Swiatecka J; Pałka J
Gynecol Endocrinol; 2001 Jun; 15(3):225-33. PubMed ID: 11447735
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts.
Surazynski A; Jarzabek K; Haczynski J; Laudanski P; Palka J; Wolczynski S
Int J Mol Med; 2003 Nov; 12(5):803-9. PubMed ID: 14533013
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
4. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
5. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.
Nilsson UW; Garvin S; Dabrosin C
Breast Cancer Res Treat; 2007 May; 102(3):253-61. PubMed ID: 17031577
[TBL] [Abstract][Full Text] [Related]
6. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
[TBL] [Abstract][Full Text] [Related]
7. Enhanced prolidase activity and decreased collagen content in breast cancer tissue.
Cechowska-Pasko M; Pałka J; Wojtukiewicz MZ
Int J Exp Pathol; 2006 Aug; 87(4):289-96. PubMed ID: 16875494
[TBL] [Abstract][Full Text] [Related]
8. Effects of tibolone on human breast cancer cells and human vascular coronary cells.
Mueck AO; Lippert C; Seeger H; Wallwiener D
Arch Gynecol Obstet; 2003 Jan; 267(3):139-44. PubMed ID: 12552324
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
10. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
11. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.
De Soto JA; Bowen D; Davis JH; Southerland WM; Hawkins M
Anticancer Res; 2002; 22(2A):1007-9. PubMed ID: 12014617
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
14. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.
Larrosa M; González-Sarrías A; García-Conesa MT; Tomás-Barberán FA; Espín JC
J Agric Food Chem; 2006 Mar; 54(5):1611-20. PubMed ID: 16506809
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
16. Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3).
Kanagaraj P; Vijayababu MR; Ilangovan R; Senthilkumar K; Venkataraman P; Aruldhas MM; Arunakaran J
Clin Chim Acta; 2007 Feb; 377(1-2):70-8. PubMed ID: 17083925
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
[TBL] [Abstract][Full Text] [Related]
18. Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells.
Gao ZO; Gao ZP; Fields JZ; Boman BM
Anticancer Res; 2002; 22(3):1379-83. PubMed ID: 12168814
[TBL] [Abstract][Full Text] [Related]
19. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
Nilsson UW; Dabrosin C
Cancer Res; 2006 May; 66(9):4789-94. PubMed ID: 16651433
[TBL] [Abstract][Full Text] [Related]
20. Effects of raloxifene hydrochloride on endometrial cancer cells in vitro.
Hibner M; Magrina JF; Lefler SR; Cornella JL; Pizarro AR; Loftus JC
Gynecol Oncol; 2004 Jun; 93(3):642-6. PubMed ID: 15196858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
